KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	125,015	126,257	130,087	119,532	113,270	105,534
Revenue Growth	-6.48%	-2.94%	8.83%	5.53%	7.33%	2.56%
Gross Profit Gross Profit Growth	49,109	51,623	59,536	51,408	50,168	49,441
Operating Income Operating Income Growth	2,501	3,509	12,547	6,006	5,121	5,004
Net Income Net Income Growth	388	3,448	9,086	5,322	4,723	3,932
Earnings Per Share EPS Growth	6.75	60.02	158.16	92.73	82.42	68.62
EPS Growth	-95.84%	-62.05%	70.55%	12.51%	20.11%	-35.86%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Japan Japan Growth	87,113	84,158	82,581	74,770	69,725
Overseas Overseas Growth	693	8,860	386	308	1,033
Unallocated Unallocated Growth	38,451	37,068	36,564	38,190	34,775
Total Total Growth	126,257	130,086	119,531	113,268	105,533

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	23,236	15,081	16,514	13,985	19,394	27,494
Total Debt Total Debt Growth	23,168	23,785	28,439	20,946	21,277	21,624
Net Cash (Debt) Net Cash Growth	68	-8,704	-11,925	-6,961	-1,883	5,870
Net Cash Growth	-	-	-	-	-	-34.50%
Net Cash Per Share Net Cash Per Share Growth	1.18	-151.51	-207.58	-121.29	-32.86	102.44

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	12,188	6,381	3,506	1,549	2,008	6,346
Capital Expenditures CapEx Growth	-3,440	-3,864	-5,697	-5,778	-6,330	-2,444
Free Cash Flow Free Cash Flow Growth	8,748	2,517	-2,191	-4,229	-4,322	3,902
Free Cash Flow Growth	158.89%	-	-	-	-	247.77%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	39.28%	40.89%	45.77%	43.01%	44.29%	46.85%
Operating Margin	2.00%	2.78%	9.64%	5.03%	4.52%	4.74%
Pretax Margin	0.42%	3.52%	9.82%	5.87%	6.10%	4.94%
Profit Margin	0.31%	2.73%	6.98%	4.45%	4.17%	3.73%
FCF Margin	7.00%	1.99%	-1.68%	-3.54%	-3.82%	3.70%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	25.000	57.000	52.000	52.000	52.000	52.000
Dividend Per Share Growth	-56.14%	9.62%	0%	0%	0%	-30.67%
Dividend Yield	2.31%	3.46%	3.46%	2.87%	3.05%	2.93%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	159.94	27.41	9.50	19.56	20.68	25.90
Forward PE	39.13	20.76	20.70	17.98	18.11	30.61
P/FCF Ratio	7.09	37.54	-	-	-	26.10
PS Ratio	0.50	0.75	0.66	0.87	0.86	0.97

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error